CARVOLIX SA (CVX.PA) Fundamental Analysis & Valuation

EPA:CVX • FR0013333077

Current stock price

3.03 EUR
-0.2 (-6.19%)
Last:

This CVX.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CVX.PA Profitability Analysis

1.1 Basic Checks

  • In the past year CVX has reported negative net income.
  • CVX had a negative operating cash flow in the past year.
  • In the past 5 years CVX always reported negative net income.
  • In the past 5 years CVX always reported negative operating cash flow.
CVX.PA Yearly Net Income VS EBIT VS OCF VS FCFCVX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

  • The Return On Assets of CVX (-24.64%) is worse than 76.19% of its industry peers.
  • The Return On Equity of CVX (-69.84%) is worse than 79.37% of its industry peers.
Industry RankSector Rank
ROA -24.64%
ROE -69.84%
ROIC N/A
ROA(3y)-25.74%
ROA(5y)-24.09%
ROE(3y)-47.78%
ROE(5y)-43.59%
ROIC(3y)N/A
ROIC(5y)N/A
CVX.PA Yearly ROA, ROE, ROICCVX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40 -50

1.3 Margins

  • Looking at the Gross Margin, with a value of 1.34%, CVX is doing worse than 90.48% of the companies in the same industry.
  • CVX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 1.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CVX.PA Yearly Profit, Operating, Gross MarginsCVX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. CVX.PA Health Analysis

2.1 Basic Checks

  • CVX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CVX has been increased compared to 1 year ago.
  • Compared to 5 years ago, CVX has more shares outstanding
  • Compared to 1 year ago, CVX has an improved debt to assets ratio.
CVX.PA Yearly Shares OutstandingCVX.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2019 2020 2021 2022 2023 2024 10M 20M 30M
CVX.PA Yearly Total Debt VS Total AssetsCVX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of 0.48, we must say that CVX is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 0.48, CVX is not doing good in the industry: 74.60% of the companies in the same industry are doing better.
  • CVX has a Debt/Equity ratio of 1.00. This is a neutral value indicating CVX is somewhat dependend on debt financing.
  • The Debt to Equity ratio of CVX (1.00) is worse than 79.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Altman-Z 0.48
ROIC/WACCN/A
WACC7.82%
CVX.PA Yearly LT Debt VS Equity VS FCFCVX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 1.07 indicates that CVX should not have too much problems paying its short term obligations.
  • The Current ratio of CVX (1.07) is worse than 71.43% of its industry peers.
  • A Quick Ratio of 1.07 indicates that CVX should not have too much problems paying its short term obligations.
  • CVX has a Quick ratio of 1.07. This is comparable to the rest of the industry: CVX outperforms 47.62% of its industry peers.
Industry RankSector Rank
Current Ratio 1.07
Quick Ratio 1.07
CVX.PA Yearly Current Assets VS Current LiabilitesCVX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2019 2020 2021 2022 2023 2024 5M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. CVX.PA Growth Analysis

3.1 Past

  • CVX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.83%, which is quite impressive.
EPS 1Y (TTM)29.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.63%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to decrease by -5.53% on average over the next years.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-5.15%
EPS Next 2Y-27.22%
EPS Next 3Y-5.53%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CVX.PA Yearly Revenue VS EstimatesCVX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2024 2026 2027 2M 4M 6M 8M 10M
CVX.PA Yearly EPS VS EstimatesCVX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

0

4. CVX.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CVX. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CVX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CVX.PA Price Earnings VS Forward Price EarningsCVX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CVX.PA Per share dataCVX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6

4.3 Compensation for Growth

  • CVX's earnings are expected to decrease with -5.53% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-27.22%
EPS Next 3Y-5.53%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CVX.PA Dividend Analysis

5.1 Amount

  • No dividends for CVX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CVX.PA Fundamentals: All Metrics, Ratios and Statistics

CARVOLIX SA

EPA:CVX (3/13/2026, 7:00:00 PM)

3.03

-0.2 (-6.19%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-02
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners6.66%
Ins Owner ChangeN/A
Market Cap179.50M
Revenue(TTM)4.12M
Net Income(TTM)-14.74M
Analysts85
Price Target3.91 (29.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)15%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 43.59
P/FCF N/A
P/OCF N/A
P/B 8.5
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.38
EYN/A
EPS(NY)-0.79
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0.07
BVpS0.36
TBVpS-0.43
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -24.64%
ROE -69.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 1.34%
FCFM N/A
ROA(3y)-25.74%
ROA(5y)-24.09%
ROE(3y)-47.78%
ROE(5y)-43.59%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 7.85%
Cap/Sales 4.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.07
Quick Ratio 1.07
Altman-Z 0.48
F-Score5
WACC7.82%
ROIC/WACCN/A
Cap/Depr(3y)6.62%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.63%
EPS Next Y-5.15%
EPS Next 2Y-27.22%
EPS Next 3Y-5.53%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y7.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3.76%
EBIT Next 3Y-21.3%
EBIT Next 5YN/A
FCF growth 1Y-9.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.51%
OCF growth 3YN/A
OCF growth 5YN/A

CARVOLIX SA / CVX.PA Fundamental Analysis FAQ

What is the fundamental rating for CVX stock?

ChartMill assigns a fundamental rating of 1 / 10 to CVX.PA.


What is the valuation status for CVX stock?

ChartMill assigns a valuation rating of 0 / 10 to CARVOLIX SA (CVX.PA). This can be considered as Overvalued.


What is the profitability of CVX stock?

CARVOLIX SA (CVX.PA) has a profitability rating of 0 / 10.


What is the expected EPS growth for CARVOLIX SA (CVX.PA) stock?

The Earnings per Share (EPS) of CARVOLIX SA (CVX.PA) is expected to decline by -5.15% in the next year.